Chimin Health Management Co., Ltd.

Equities

603222

CNE100002193

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
5.94 ^CNY	+3.30%		+8.39%	-25.84%

Apr. 25	Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 25	Chimin Health Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Tranche Update on Chimin Health Management Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023.

January 02, 2024

From July 24, 2023 to December 31, 2023, the company has repurchased 6,364,800 shares, representing 1.18% for CNY 59.64 million. With this, the company has completed the repurchase of 6,364,800 shares, representing 1.18% for CNY 59.64 million under the buyback announced on July 25, 2023.

Latest news about Chimin Health Management Co., Ltd.

Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Tranche Update on Chimin Health Management Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023.	Apr. 01	CI
Tranche Update on Chimin Health Management Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023.	Jan. 02	CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Chimin Health Management Secures Exclusive Rights to Japanese Cell Therapy Tech	23-10-17	MT
Chimin Health Management Co., Ltd.(XSSC:603222) added to S&P Global BMI Index	23-09-18	CI
Chimin Health Management Co., Ltd. announces an Equity Buyback for CNY 120 million worth of its shares.	23-07-24	CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-24	CI
Chimin Health Management Co., Ltd. authorizes a Buyback Plan.	23-07-23	CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-19	CI
Chimin Health Management Co., Ltd. announced that it has received CNY 489.999998 million in funding	22-12-28	CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-21	CI
Chimin Health Management Co., Ltd. announced that it expects to receive CNY 900 million in funding	22-04-06	CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-22	CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-12	CI
Chimin Health Management Co., Ltd.(SHSE:603222) dropped from Shanghai Stock Exchange Health Care Sector Index	21-06-11	CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI
Chimin Health Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-28	CI
Chimin Health Management Co., Ltd. announced that it has received CNY 241.246533 million in funding from Shanghai Chunda Asset Management Co., Ltd., Shenzhen Zongguan Capital Management Co., Ltd., Caitong Fund Management Co., Ltd., and other investors	21-04-11	CI
China stocks rise on infra boost, Sino-U.S. tensions cap gains	21-03-11	RE

Chart Chimin Health Management Co., Ltd.

Duration

Period

Chart Chimin Health Management Co., Ltd.

More charts

Company Profile

Chimin Health Management Co., Ltd., formerly Zhejiang Chimin Pharmaceutical CO., Ltd, is primarily engaged in the research, development, manufacture and sale of infusion and injection and puncture machinery products. The Company primarily produces Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, as well as injection and puncture machinery products, including safety syringe, sterile syringes and infusion sets. The Company distributes its products within domestic market and to overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-29 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Medical Supplies

	1st Jan change	Capi.
CHIMIN HEALTH MANAGEMENT CO., LTD.	-25.84%	435M
COLOPLAST A/S	+11.84%	27.79B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-32.98%	2.98B
WINNER MEDICAL CO., LTD.	-15.97%	2.52B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+11.90%	2.34B
HARTALEGA HOLDINGS	-1.11%	1.91B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-13.37%	1.83B
TOP GLOVE CORPORATION BHD.	-7.78%	1.39B
NAKANISHI INC.	-0.38%	1.27B
KANGJI MEDICAL HOLDINGS LIMITED	+4.01%	1.13B

Medical Supplies